Blogs about: Xl765
Featured Blog
Exelixis PI3K/mTOR Inhibitor XL765 effective in Phase I
Phase I data presented at the EORTC-NCI-AACR Symposium show Exelixis PI3K/mTOR kinase inhbitor XL765 to show demonstrate ‘robust pharmacodymanics’… more →
Kinase News
Exelixis PI3K/mTOR Inhibitor XL765 effective in Phase I
crimsoncanary wrote 1 year ago: Phase I data presented at the EORTC-NCI-AACR Symposium show Exelixis PI3K/mTOR kinase inhbitor XL765 … more →
Exelixis begin Phase I trial of PI3K/mTOR inhibitor XL765 in Glioma
crimsoncanary wrote 1 year ago: Exelixis are initiating a Phase I trial of XL765, in combination with Temozolomide, for the treatmen … more →
Phase I data on Exelixis PI3K/mTor inhibitor XL765
crimsoncanary wrote 1 year ago: Data presented at ASCO show Exelixis’ PI3K/mTor inhibitor XL765 to be safe in a Phase I trials … more →
